Potentially huge legal issues are hovering over Kenvue. But Kimberly-Clark, which agreed to buy it for $40 billion, appears to think they’re manageable.Potentially huge legal issues are hovering over Kenvue. But Kimberly-Clark, which agreed to buy it for $40 billion, appears to think they’re manageable. internal-storyline-no, Kenvue Inc, Kimberly-Clark Corporation, Mergers, Acquisitions and Divestitures, Tylenol (Drug), Autism, Liability for Products, Stocks and Bonds, Johnson & Johnson, Starboard Value LP Read More
The Gamble Behind a Takeover of Kenvue, Maker of Tylenol
